Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Aug 27;19(10):86.
doi: 10.1007/s11892-019-1212-8.

Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes

Caitlin W Hicks  1 , Elizabeth Selvin  2
Affiliations
Review

Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes

Caitlin W Hicks et al. Curr Diab Rep. .

Abstract

Purpose of review: Diabetic peripheral neuropathy eventually affects nearly 50% of adults with diabetes during their lifetime and is associated with substantial morbidity including pain, foot ulcers, and lower limb amputation. This review summarizes the epidemiology, risk factors, and management of diabetic peripheral neuropathy and related lower extremity complications.

Recent findings: The prevalence of peripheral neuropathy is estimated to be between 6 and 51% among adults with diabetes depending on age, duration of diabetes, glucose control, and type 1 versus type 2 diabetes. The clinical manifestations are variable, ranging from asymptomatic to painful neuropathic symptoms. Because of the risk of foot ulcer (25%) and amputation associated with diabetic peripheral neuropathy, aggressive screening and treatment in the form of glycemic control, regular foot exams, and pain management are important. There is an emerging focus on lifestyle interventions including weight loss and physical activity as well. The American Diabetes Association has issued multiple recommendation statements pertaining to diabetic neuropathies and the care of the diabetic foot. Given that approximately 50% of adults with diabetes will be affected by peripheral neuropathy in their lifetime, more diligent screening and management are important to reduce the complications and health care burden associated with the disease.

Keywords: Lower extremity disease; Microvascular complications; Peripheral neuropathy; Type 1 diabetes; Type 2 diabetes.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

Caitlin W. Hicks declares that she has no conflict of interest.

Elizabeth Selvin is a PI of grants from the Foundation for the National Institutes of Health and the National Kidney Foundation, but that is unrelated to this topic.

References

    1. Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Malik RA, et al. Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes Care. 2017;40(1):136–154.10.2337/dc16-2042. - DOI - PMC - PubMed

    2. ••This article describes the most recent position statment from the American Diabetes Association about the workup and management of diabetic neuropathy.

    1. Gregg EW, Gu Q, Williams D, de Rekeneire N, Cheng YJ, Geiss L, et al. Prevalence of lower extremity diseases associated with normal glucose levels, impaired fasting glucose, and diabetes among U.S. adults aged 40 or older. Diabetes Res Clin Pract. 2007;77(3):485–488.10.1016/j.diabres.2007.01.005 - DOI - PubMed
    1. Boulton AJ. Diabetic neuropathy and foot complications. Handb Clin Neurol. 2014;126:97–107.10.1016/B978-0-444-53480-4.00008-4 - DOI - PubMed
    1. Boulton AJ. The pathway to foot ulceration in diabetes. Med Clin North Am. 2013;97(5):775–790.10.1016/j.mcna.2013.03.007 - DOI - PubMed
    1. Kumar S, Ashe HA, Parnell LN, Fernando DJ, Tsigos C, Young RJ, et al. The prevalence of foot ulceration and its correlates in type 2 diabetic patients: a population-based study. Diabet Med. 1994;11(5):480–484 - PubMed

Publication types